MORE FRUIT, LESS SUGAR FRUITTELLA EXTENDS REDUCED SUGAR RANGE
Following the huge success of its 30% less sugar chewy bags earlier this year, Fruittella has added two delicious new products to its popular range. Jelly Foams and Gummies bursting with real fruit juice flavours are now part of the family favourite collection, making it one of the most innovative and exciting reduced sugar confectionery offerings on the market.
92% of consumers are consciously purchasing goods with a lower percentage of sugar, and thanks to Fruittella’s ever-growing collection of sweets, retailers can ensure they are meeting consumer demand. With the Fruittella Sugar Fee, 30% Less Sugar and the Classic Sugar Based Range, shoppers can pick and choose their favourite treats, knowing that they come with the Fruittella trusted seal of quality.
The new Gummies and Jelly Foams are both available in re-sealable bags, making them ideal as on the go snacks, or in the run up to the Christmas a great sweet treat to share with friends and family. The reduced sugar collection sits alongside the classic Fruittella range offering incremental growth with the brand +15% YTD.
Matthew Navier, Fruittella Brand Manager says, “Our new Fruittella 30% less sugar sharing bags are part of a strategic decision to expand our range offering consumers conscious choices. It’s key that we’re not only offering consumers an alternative, but one that tastes great and comes in a variety of formats.
The new Gummies and Jelly Foams complement our existing chewy bags, and give shoppers more choice when it comes to choosing a treat that is a little bit better for them. Stocking a complete range of reduced sugar confectionery alongside our classic core range gives retailers the opportunities to drive incremental sales, and conform to government guidelines and guidance from Public Health England.”
The launches of Fruittella 30% Less Sugar has been supported by £1.5 million marketing spend, and the range is a key product for the brand which will see over a million samples being trialled across the UK in the coming months.